| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |